Lite Strategy, Inc.

US$1.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LITSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (26.92%)
Div yield —
ROE (60.95%)
Biotechnology
Beta (5Y) 0.04
PE TTM —
TSR TTM (51.20%)
Mkt cap US$31.02M
ROIC (25.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.07
4.90%
(49.08%)
Hold 12|4|10|0|11
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
23.97%
16.79%
14.33%
15.90%
Revenue$M
3.351
3.275
3.364
3.266
(1.62%)
(4.63%)
0.26%
(2.77%)
Peers (US$31.02M)
Cap (US$)
PE
32.83M
—
31.04M
—
Capital
TTM
5Y
10Y
Leveragex
0.445
0.029
0.011
EBIT/Intx
1.198
0.167
0.168
Own earn%
537.21
27.34
19.69
Sh yield%
37.76
22.85
21.77
Owners
Insiders/Inst%
11.51
30.79
Short interest%
3.86
SBC / revenue%
1.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
16–26
$1 testx
0.0
Incr. ROIC%
2